100 mg & 200 mg
Fenofibrate: djunct to dietary therapy for the treatment of adults with elevations of serum triglyceride levels (types IV and V hyper lipidemia); adjunct to dietary therapy for the reduction of low density lipoprotein cholesterol (LDL-C), total cholesterol (total-C), triglycerides, and apolipoprotein B (apo B) in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson types IIa and IIb)
Dosage and Administration:
Standard micronised formulations of fenofibrate are available as 67-mg capsules to be taken several times daily, or as 200- or 267-mg capsules for once daily dosage. The usual initial dose is 67mg three times daily or 200mg once daily; the dose may be reduced to 67mg twice daily or increased to 67mg four times daily or 267mg once daily according to response.
Liver function tests increased, Headache, Abdominal pain, constipation, nausea, Back pain, CPK increased, Respiratory disorder, Rhinitis and Rhabdomyolysis.